Icon

KLONOPIN RAPIDLY DISINTEGRATING (nda020813)- (0.125MG,0.25MG,0.5MG,1MG,2MG)

CLONAZEPAM ROCHE
0.125MG,0.25MG,0.5MG,1MG,2MG
No No
2000-Feb-01 Expired
None None
None No
Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. Klonopin is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.
4 0 4
Total Other Developers None
Drugs with Suitability No
0.125MG ** ** - - 4
0.25MG ** ** - - 4
0.5MG ** ** - 4 -
1MG ** ** - 4 -
2MG ** ** - - 4
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** **** *** *** ************** ********** ******* *********** **** **. *-**, ********** **** *****-**** *, *.*.*. *****, ******, ****** ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.